Company Filing History:
2 out of 5,463 
2 out of 28 
1 out of 13 Years Active: 2019-2025
Title: Innovations of Johannes De Haard
Introduction
Johannes De Haard is a notable inventor based in Oudelande, Netherlands. He has made significant contributions to the field of medical treatments, particularly in the area of autoimmune diseases. With a total of 3 patents to his name, De Haard's work focuses on novel therapeutic methods that leverage FcRn antagonists.
Latest Patents
One of his latest patents is titled "Use of FCRN antagonists for treatment of generalized myasthenia gravis." This patent outlines innovative methods for treating generalized myasthenia gravis by administering an effective amount of an isolated FcRn antagonist. The methods described involve antagonists that bind to FcRn with increased affinity and reduced pH dependence compared to the native Fc region. Another significant patent is "FcRn antagonists and methods of use," which details compositions of FcRn antagonists that enhance CD16 binding affinity. This patent also includes methods for treating antibody-mediated disorders, such as autoimmune diseases, using these compositions.
Career Highlights
Throughout his career, Johannes De Haard has worked with prominent organizations, including the University of Texas System and Argenx B.V. His research and innovations have contributed to advancements in therapeutic strategies for complex medical conditions.
Collaborations
Some of his notable coworkers include Peter Ulrichts and Torsten Dreier, who have collaborated with him on various projects related to his patents and research.
Conclusion
Johannes De Haard's contributions to the field of medical innovation, particularly through his patents on FcRn antagonists, highlight his role as a significant inventor in the treatment of autoimmune diseases. His work continues to influence the development of novel therapeutic approaches.